Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid Injection vs Splinting vs Combination for CTS
NCT07043179Not yet recruiting
- Start
- Jul 2025
- Primary completion
- Jul 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of triamcinolone acetonide in carpal tunnel syndrome (CTS) (3 arms). Primary endpoint: Surgical rate within 52 weeks. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT07043179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07043179.